EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE — NOT FDA APPROVED
Intermediate

Longevity Bioregulator Protocol

Requires some experience with individual compounds

Estimated Cost

$100-200 per 10-day cycle

The core Khavinson protocol combines three key bioregulators: Epithalon (pineal gland/telomeres), Vladonix (thymus/immune), and Ventfort/Vesugen (vascular health). Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.

longevityimmunitycardiovascular

Source & Attribution

Source: BioLongevity Labs / Khavinson Protocol (vendor)

Disclaimer: This protocol is based on the research of Professor Vladimir Khavinson and is marketed by BioLongevity Labs and other vendors. This listing is for educational reference only. We do not recommend or endorse specific peptide combinations. Bioregulator research is primarily from Russian sources with limited Western clinical validation. Consult a healthcare provider before use.

Component Breakdown

Each component in this stack serves a specific purpose. Click any peptide to learn more.

Pineal gland — telomerase activation, melatonin regulation

longevityView Details

Vladonix / Thymagen

Thymus — T-cell production, immune restoration

Ventfort / Vesugen

Blood vessels — circulation, atherosclerosis prevention

Protocol Timing

Cyclical Protocol (Khavinson Method)

Bioregulators work best in cycles, not continuous use

110-day cycle: Take all 3 bioregulators daily
220-day break: Off completely
3Repeat 2-3 times per year
4Best taken in morning on empty stomach

Expected Benefits Timeline

Days 1-10

Cycle 1

Initial cellular signalingSleep improvementEnergy stabilization
Days 11-20

Break

Integration periodSubtle changes continue
Cycle 2-3

Months 1-3

Immune function improvementBetter circulationHormonal balance
Long-term

6+ months

Telomere maintenanceSystemic anti-agingDisease risk reduction

Warnings & Contraindications

  • Bioregulators are taken in cycles (10-30 days), not continuously
  • Effects build over 2-3 cycles
  • Based on Russian research — limited Western clinical data
  • Individual responses may vary
  • Not evaluated by the FDA

General Stack Safety: When combining multiple compounds, the risk of interactions increases. Start with lower doses of individual components before combining. Discontinue use and consult a healthcare provider if you experience any adverse effects.

Related Stacks

Research Reference Only

This stack is for educational purposes. Combining peptides may increase risks. Start with individual compounds to assess tolerance. This information does not constitute medical advice. Consult a qualified healthcare provider before starting any protocol.